Lexeo Therapeutics, Inc. (LXEO) Discusses Phase III Program Design and Durable Cardiac Improvements in Friedreich's Ataxia Transcript

Discusses Phase III Program Design and Durable Cardiac Improvements in Friedreich's Ataxia June 29, 2026 2:00 PM ...
Heart

Feasibility of early double sequential defibrillation in out-of-hospital cardiac arrest: the double-D randomised pilot trial

Background Double sequential defibrillation (DSD) is a promising treatment for patients with out-of-hospital cardiac arrest ...
Thorax

Comparative performance of endobronchial ultrasound-guided sampling techniques in patients with mediastinal lesions: a network meta-analysis

Background Comparative evidence on the diagnostic yield of endobronchial ultrasound (EBUS)-guided sampling techniques for ...
Scientific Research PublishingOpinion

Beyond the Cutoff: An Argument for Extending the Audit Scope beyond the Balance Date to Enhance Financial Reporting Integrity ()

The traditional audit approach delineates a sharp boundary at the balance sheet date, focusing subsequent events procedures ...